Kinases are a group of enzymes that transfer phosphate groups to proteins, thereby modulating their activity. In cancer, certain kinases, such as the epidermal growth factor receptor (EGFR) kinase, are often mutated or overexpressed. These mutations can lead to continuous cell growth and division, contributing to tumorigenesis. Targeting kinases with specific inhibitors has become a key strategy in cancer treatment.
